| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |